Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001842952-21-000007
Filing Date
2021-11-01
Accepted
2021-11-01 16:10:05
Documents
2
Period of Report
2021-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_163579739102406.html 3  
1 FORM 3 wf-form3_163579739102406.xml 3 1719
2 POA FOR JENNIFER MINAI-AZARY ex-24.htm EX-24 3965
  Complete submission text file 0001842952-21-000007.txt   7181
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 267-225-7416
Context Therapeutics Inc. (Issuer) CIK: 0001842952 (see all company filings)

EIN.: 472566423 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 MILLER AVENUE SUITE 100 ANN ARBOR MI 48104
Business Address
Minai-Azary Jennifer Lynn (Reporting) CIK: 0001844398 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40654 | Film No.: 211367239